Mexico Pharmaceutical Packaging Market Size, Growth, Trends and Demand Report 2026–2034

Mexico Pharmaceutical Packaging Market Report 2026

Market Size in 2025: USD 2,217.4 Million

Market Forecast in 2034: USD 4,524.3 Million

Market Growth Rate: 8.00% (2026–2034)

According to the latest report by IMARC Group, titled "Mexico Pharmaceutical Packaging Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026-2034," the Mexico Pharmaceutical Packaging market size reached USD 2,217.4 Million in 2025. Looking ahead, IMARC Group expects the market to reach USD 4,524.3 Million by 2034, exhibiting a compound annual growth rate (CAGR) of 8.00% during 2026-2034.

Request a Free Sample PDF for Detailed Market Insights:  https://www.imarcgroup.com/report/es/mexico-pharmaceutical-packaging-market/requestsample

Mexico Pharmaceutical Packaging Industry Trends and Demands in 2026:

Mexico's pharmaceutical packaging market is experiencing high-growth expansion driven by record pharmaceutical manufacturing investment acceleration as global pharma companies establish or expand Mexico production facilities capitalizing on nearshoring supply chain diversification, growing Mexico domestic pharmaceutical market creating higher pack volume demand across oral solid dose, liquid, and injectable product categories, strengthening COFEPRIS packaging regulatory compliance requirements mandating child-resistant, tamper-evident, and serialization-compliant packaging systems, expanding biologics and biosimilar pharmaceutical manufacturing creating new primary container demand for specialized parenteral and pre-filled delivery formats, and increasing contract packaging organization growth serving both domestic and export pharmaceutical manufacturing customers. The market covers plastics and polymers including PVC, PP, PET, PE, PS, and others; paper and cardboard; glass; foil; and other material categories. Primary packaging products include plastic bottles, lids and closures, parenteral containers, blisters, pre-fillable inhalers, bags, and medication tubes. Secondary packaging covers prescription containers and pharmaceutical packaging accessories. Tertiary packaging serves bulk shipping and distribution requirements. End-user segments include pharmaceutical manufacturing, contract packaging, retail pharmacy, and institutional pharmacy. Mexico's pharmaceutical manufacturing nearshoring boom is the dominant market growth driver as international pharmaceutical companies redirect production investment from Asia toward Mexico to capitalize on USMCA trade benefits, proximity to US market, and competitive manufacturing cost structures. COFEPRIS serialization and track-and-trace packaging compliance requirements are driving packaging line upgrade investment across Mexico's pharmaceutical manufacturer community. Biologic and injectable pharmaceutical product growth is driving parenteral container and pre-filled syringe primary packaging demand growth at premium specification standards. Blister packaging adoption is expanding for oral solid dose pharmaceutical product primary packaging across both branded and generic drug segments.

The market reflects Mexico's pharmaceutical packaging sector advancement from predominantly imported packaging material dependency toward growing domestic manufacturing capability investment as pharma production scale justifies local packaging supplier development. Glass parenteral container demand is sustained through Mexico's growing injectable pharmaceutical manufacturing output despite ongoing industry conversation about glass-to-polymer conversion for certain format categories. PVC and aluminum foil blister packaging maintains dominant share for oral solid dose primary packaging across Mexico's generic and branded pharmaceutical product portfolios. PET and HDPE plastic bottles serve oral liquid and topical pharmaceutical product primary packaging requirements. Sustainable packaging material transition is an emerging consideration as Mexico's pharmaceutical manufacturers respond to global corporate sustainability packaging commitments alongside COFEPRIS regulatory baseline compliance. Contract packaging organization capacity is expanding as pharmaceutical manufacturers increasingly outsource packaging operations to enable production flexibility and capital investment efficiency.

How AI is Reshaping the Future of the Mexico Pharmaceutical Packaging Market:

AI-Powered Serialization Compliance and Track-and-Trace Management:
AI integrates real-time packaging line vision inspection, serialization code generation, database registration, and shipment verification data flows to ensure continuous COFEPRIS track-and-trace serialization compliance across pharmaceutical packaging operations in Mexico. Machine learning models improve serial code readability verification accuracy and anomaly detection sensitivity across diverse packaging material surface, label placement, and production speed condition combinations. These capabilities enable Mexico's pharmaceutical manufacturers and contract packagers to maintain robust serialization compliance without manual verification bottlenecks, reduce serialization error rates that trigger costly packaging line stops and product investigation requirements, and support continuous COFEPRIS regulatory compliance audit readiness through comprehensive automated packaging serialization event record generation.

Vision-Based Quality Inspection and Defect Detection:
AI-powered machine vision systems inspect pharmaceutical packaging output including blister pack seal integrity, fill level accuracy, label placement correctness, closure torque adequacy, and container dimensional specification compliance at production line speeds with superior consistency and detection sensitivity compared to conventional sampling inspection approaches. Machine learning models trained on pharmaceutical packaging defect image datasets improve detection accuracy across diverse package format, material, and defect morphology combinations enabling comprehensive 100% inspection implementation. These technologies support Mexico's pharmaceutical packaging manufacturers in achieving the zero-defect quality delivery standards required by pharmaceutical manufacturer GMP compliance expectations, reduce batch rejection risk from packaging quality escapes identified during finished product release testing, and improve overall packaging line yield efficiency reducing material waste from unnecessarily broad defect rejection margins.

Intelligent Packaging Design and Regulatory Submission Support:
AI analyzes COFEPRIS packaging regulatory requirement databases, international pharmacopoeia primary container specification standards, pharmaceutical product compatibility testing protocol requirements, and sustainable material substitution feasibility data to generate compliant pharmaceutical packaging design configuration recommendations and regulatory submission documentation support for new product registrations and packaging change management processes. Machine learning models improve regulatory requirement interpretation accuracy across diverse pharmaceutical product category, packaging format, and market registration scope combinations. These capabilities accelerate packaging regulatory approval timelines for Mexico pharmaceutical manufacturers introducing new products or packaging changes, reduce regulatory submission error rates requiring costly revision cycles, and support packaging development teams in navigating Mexico's pharmaceutical packaging regulatory compliance landscape efficiently alongside global market registration requirements.

Mexico Pharmaceutical Packaging Market Segmentation:

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Mexico Pharmaceutical Packaging market share. It includes forecasts for the period 2026-2034 and historical data from 2020-2025 for the following segments.

Material Insights:

Plastics and Polymers:

• Polyvinyl Chloride (PVC)
• Polypropylene (PP)
• Polyethylene Terephthalate (PET)
• Polyethylene (PE)
• Polystyrene (PS)
• Others

Paper and Cardboard

Glass

Foil

Others

Product Insights:

Primary Packaging:

• Plastic Bottles
• Lids and Closures
• Parenteral Containers
• Blisters
• Pre-Fillable Inhalers
• Bags
• Medication Tubes
• Others

Secondary Packaging:

• Prescription Containers
• Pharmaceutical Packaging Accessories

Tertiary Packaging

End-User Insights:

• Pharmaceutical Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy

Regional Insights:

• Northern Mexico
• Central Mexico
• Southern Mexico
• Others

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of all major companies in the Mexico Pharmaceutical Packaging industry.

• Amcor plc (Mexico)
• Berry Global Group (Mexico)
• AptarGroup, Inc. (Mexico)
• Gerresheimer AG (Mexico)
• Becton, Dickinson and Company (Mexico)
• Envases Universales S.A. de C.V.

Recent News and Developments in Mexico Pharmaceutical Packaging Market

April 2026: Amcor Mexico announced expanded pharmaceutical blister packaging and flexible packaging production capacity investment targeting growing demand from nearshoring international pharmaceutical manufacturers establishing or scaling Mexico production operations, alongside new sustainable pharmaceutical packaging material development program launches targeting eco-compliant primary and secondary packaging format innovations for COFEPRIS compliance and global pharmaceutical brand sustainability commitment alignment.

March 2026: Mexico's COFEPRIS announced updated pharmaceutical serialization and track-and-trace regulation enforcement timeline confirmations and expanded GMP-compliant pharmaceutical packaging facility inspection program enhancement, directly stimulating packaging line technology upgrade investment and AI-powered serialization compliance system adoption among Mexico's pharmaceutical manufacturer and contract packager community.

Ongoing: Increasing investments in nearshoring pharmaceutical manufacturing packaging supply chain localization, COFEPRIS serialization compliance system deployment, injectable and biologic primary container capacity development, blister packaging line upgrade and automation investment, sustainable pharmaceutical packaging material development, contract packaging organization capacity expansion, and AI-powered quality inspection and regulatory compliance documentation platform adoption continue to reshape the Mexico Pharmaceutical Packaging market.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services including thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:                                                                                

Street: 563-13 Kamien

Area: Iwata

Country: Tokyo, Japan

Postal Code: 4380111

Email: sales@imarcgroup.com

Source: IMARC Group